UBS Group AG vs Pfizer
Vergelijking van marktkapitalisatie in de tijd
UBS Group AG
$135.0B
Rang #132
Pfizer
$138.6B
Rang #130
Marktkapitalisatie in de tijd
Belangrijke momenten
- Pfizer streefde UBS Group AG voorbij tegen 1998
- UBS Group AG streefde Pfizer voorbij tegen 1999
- Pfizer streefde UBS Group AG voorbij tegen 2008
Jaar-op-jaarvergelijking
| Jaar | UBS Group AG | Pfizer | Koploper |
|---|---|---|---|
| 2026 | $135.0B | $138.6B | Pfizer |
| 2025 | $131.3B | $137.3B | Pfizer |
| 2024 | $94.7B | $136.4B | Pfizer |
| 2023 | $86.7B | $139.5B | Pfizer |
| 2022 | $55.5B | $237.5B | Pfizer |
| 2021 | $51.4B | $265.1B | Pfizer |
| 2020 | $38.1B | $159.1B | Pfizer |
| 2019 | $35.0B | $154.3B | Pfizer |
| 2018 | $33.2B | $165.8B | Pfizer |
| 2017 | $46.8B | $132.8B | Pfizer |
| 2016 | $41.6B | $114.6B | Pfizer |
| 2015 | $48.1B | $109.7B | Pfizer |
| 2014 | $40.5B | $102.5B | Pfizer |
| 2013 | $39.6B | $97.3B | Pfizer |
| 2012 | $32.4B | $77.1B | Pfizer |
| 2011 | $25.2B | $64.0B | Pfizer |
| 2010 | $34.5B | $49.7B | Pfizer |
| 2009 | $36.7B | $49.6B | Pfizer |
| 2008 | $33.4B | $45.8B | Pfizer |
| 2007 | $117.9B | $55.2B | UBS Group AG |
| 2006 | $161.9B | $60.1B | UBS Group AG |
| 2005 | $136.7B | $52.1B | UBS Group AG |
| 2004 | $104.2B | $58.3B | UBS Group AG |
| 2003 | $92.6B | $75.0B | UBS Group AG |
| 2002 | $73.5B | $63.7B | UBS Group AG |
| 2001 | $91.6B | $81.9B | UBS Group AG |
| 2000 | $95.7B | $93.5B | UBS Group AG |
| 1999 | $77.8B | $65.4B | UBS Group AG |
| 1998 | $76.4B | $83.3B | Pfizer |
| 1997 | $76.2B | $49.3B | UBS Group AG |
| 1996 | $42.6B | $27.1B | UBS Group AG |
| 1995 | $47.6B | $20.2B | UBS Group AG |